Matthew B Soellner

Title: The Innovative Contributions of Matthew B. Soellner

Introduction

Matthew B. Soellner is a prominent inventor based in Madison, WI (US). He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for various biological processes. With a total of 7 patents to his name, Soellner's work has had a substantial impact on medical research and treatment methodologies.

Latest Patents

Soellner's latest patents include groundbreaking inventions such as "Inhibitors of BCR-ABL mutants and use thereof." This patent discloses inhibitor compounds targeting Bcr-Abl and its mutants, including the Bcr-Abl T315I mutant protein. The compositions comprising these inhibitor compounds are designed for the treatment of leukemia, specifically chronic myelogenous leukemia. Another notable patent is for "Nuclease inhibitors and methods for their use." This invention introduces a class of anionic oligomers and polymers that inhibit nucleases, particularly RNase. Specific inhibitors include mixtures of oligomers of vinyl sulfate, which can be used in various biological procedures and assays.

Career Highlights

Throughout his career, Matthew B. Soellner has worked with esteemed organizations such as the Wisconsin Alumni Research Foundation and the University of Michigan. His work in these institutions has allowed him to advance his research and contribute to significant scientific discoveries.

Collaborations

Soellner has collaborated with notable scientists, including Ronald Thaddeus Raines and Laura Lee Kiessling. These collaborations have further enriched his research and expanded the scope of his inventions.

Conclusion

Matthew B. Soellner's innovative contributions to the field of biochemistry demonstrate his commitment to advancing medical science. His patents and collaborations reflect a dedication to improving treatment options for serious health conditions.